Navigation Links
John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
Date:12/7/2012

  • 686 The Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), Has Preferential Activity in the ABC Subtype of Relapsed/Refractory De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results of a Multicenter, Open-Label, Phase 2 Study, Andre Goy, MD, Oral Session: Dec. 12, 2012 Time: 4:45 PM

  • 895 SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment, K. Stephen Suh, PH.D., Oral session: Dec. 11, 2012 Time: 7:30AM

  • 904 Interim Results of an International, Multicenter, Phase 2 Study of Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Relapsed or Refractory Mantle Cell Lymphoma (MCL): Durable Efficacy and Tolerability with Longer Follow-up, Andre Goy, MD, Oral Session: Dec. 11, 2012 Time: 8:15 AM

  • 905 Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 "EMERGE" Study, Andre Goy, MD, Oral Session: Dec. 11, 2012 Time: 8:30 AM

  • 1579 Baseline Serum Cytokines Profiles in Mantle Cell Lymphoma Correlates with Outcome, Anthony R. Mato, MD, Poster: Dec. 8, 2012 Time: 5:30 PM-7:30 PM

  • 1623 A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma, Andre Goy, MD, Poster: Dec. 8, 2012 Time: 5:30 PM-7:30 PM

  • 2728 Survival of Newly Diagnosed T-Cell Lymphoma (TCL) in the Modern Era: Investigation of Prognostic Factors with Critical Examination of Therapy in a Multicenter US Cohort, Tatyana Feldman, M.D., Poster: Dec. 9, 2012 Time: 6:00 PM-8:00 PM

  • 2751 Pillar-1: Multicenter Phase 2 Study of Everolimus for Patients with Mantle Cell Lymphoma Who Are Refractory or Intolerant to Bortezomib, Andre Goy, MD, Poster: Dec. 9, 2012 Time: 6:00 PM-8:00 PM

  • 3120 Allogenic Transplantation in Lymphomas: A Focuse
    '/>"/>

  • Contact: Amy Leahing
    aleahing@p4strategy.com
    305-458-0599
    John Theurer Cancer Center
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7

    Related medicine news :

    1. John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
    2. Experts from John Theurer Cancer Center to participate in the AAMDSIF Patient and Family Conference
    3. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
    4. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
    5. Protein tied to cancer-drug resistance in mice
    6. Study compares standard against newer treatment in women whose breast cancer has spread
    7. Existing drugs may help more breast cancer patients
    8. Protein tied to cancer drug resistance in mice
    9. The effect of treating institution on outcomes in head and neck cancer
    10. New Online Resource Acts As Powerful Tool in the Battle against Cancer
    11. For Aggressive Breast Cancer, Chemo May Work Better in the Young
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... 2015 CCL, a top-ranked, global provider ... program to other leadership development consultancies. “The CCL ... and successful practitioners, expanding our capacity to drive results ... John R. Ryan, CCL President and CEO. , As ... Partner Network , it will schedule a one-on-one conference ...
    (Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
    (Date:5/4/2015)... Dr. Benjamin Stong of Kalos Facial ... latest non-surgical double-chin eliminator. Dr. Stong is double ... Atlanta to offer Kybella treatments . The FDA ... under the chin, promising to safely dissolve fat deposits ... who sought immediate solutions for their double chin were ...
    (Date:5/4/2015)... 04, 2015 Unlike some camps, the Nike Middle ... The goal is to educate first and train second, with ... ensures that the young runners are building the knowledge base needed ... of the topics covered include Effort Based Training, Running Heroes, Running ... to be? This is not a camp where kids come ...
    (Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Richard ... has been chosen to receive the America’s Best Dentist ... Dr. Champagne’s selection as a top dentist is a ... to continuing education and his compassion for his patients. ... professionals who exemplify excellence in their field. These nominees ...
    Breaking Medicine News(10 mins):Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2
    ... delivery combination selectively crosses the tight barrier that protects the ... to brain tumors, a research team led by scientists from ... the January issue of the Journal of Clinical Investigation ... the targeted particles guide payloads to image tumors, treat tumors, ...
    ... (HealthDay News) -- HIV-positive teens and young women are more likely ... who do not have HIV, a new study finds. Researchers ... aged 13 to 24, who had been treated at four hospitals ... some more than once, for a total of 96 pregnancies. ...
    ... By Serena Gordon HealthDay Reporter , TUESDAY, ... for profit are more likely to have patients who require ... who need longer times in hospice care, research reveals. ... hospices a flat daily rate, regardless of care needs -- ...
    ... research from University of Michigan says brain scans showing ... the person whose brain is being scanned. Emily ... recently led a study that scanned the brain activity ... would have an impact on their ability to quit ...
    ... from human placenta left over from live births and ... one kind of melatonin receptor, MT1. This potentially therapeutic ... laboratory test tube and animal models of stroke. ... with melatonin receptor MT2. Researchers from the University ...
    ... HealthDay Reporter , TUESDAY, Feb. 1 (HealthDay News) ... from meningococcal meningitis, a potentially deadly infection of the ... up-to-date whooping cough vaccines in light of recent outbreaks, ... American Academy of Pediatrics issues updated vaccination guidelines annually. ...
    Cached Medicine News:Health News:Targeted particle fools brain's guardian to reach tumors 2Health News:Targeted particle fools brain's guardian to reach tumors 3Health News:Targeted particle fools brain's guardian to reach tumors 4Health News:HIV Linked to Higher Pregnancy Rate in Young Women 2Health News:For-Profit Hospices May Prefer Certain Types of Patients: Study 2Health News:For-Profit Hospices May Prefer Certain Types of Patients: Study 3Health News:Brain scans predict likely success when it comes to quitting smoking 2Health News:Transplanted human placenta-derived stem cells show therapeutic potential in stroke models 2Health News:Pediatricians Issue New Vaccination Recommendations 2Health News:Pediatricians Issue New Vaccination Recommendations 3
    (Date:5/4/2015)... -- RadiologyAuction will have their first auction starting May 5 ... the end of the auction on May 27 th ... Cr,s, Agfa and Sony, printers and GE portable x-rays ... equipment will be available at later auctions each month ... buying and selling imaging equipment, the brokers at RadiologyAuction ...
    (Date:5/4/2015)... -- Makindus, Inc. a specialty pharmaceutical development company focused on ... has granted orphan drug designation for their lead candidate, ... "We are extremely pleased to now have orphan drug ... for Europe . This complements and ... States for which orphan designation has already ...
    (Date:5/4/2015)... , May 4, 2015   HeartWare International, Inc ... invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ... Doug Godshall , is scheduled to present at the ... Las Vegas on Thursday, May 14, ... The live webcast of the Company,s presentation at the conference ...
    Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
    ... As part of the Help America ... the first approved candidate with hearing instruments at no ... came into the Beaverton clinic because of hearing concerns. ... those that have hearing loss and limited financial resources ...
    ... Spectrum Control, Inc. (Nasdaq: SPEC ), a leading ... today that it will release its fourth quarter and fiscal ... close of the market. Following the release, Spectrum Control will ... discuss the Company,s operating results for the quarter and fiscal ...
    Cached Medicine Technology:Accurate Hearing & Audiology Clinics / Help America Hear - One Person at a Time 2
    4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
    Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
    For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
    A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
    Medicine Products: